参考文献:
[1].Mei M,et al.Ther Adv Med Oncol.2020 Dec 8;12:1758835920975355.
[2].Lacas B,et al.Radiother Oncol.2021 Jan 27;156:281-293.
[3].中国临床肿瘤学会.《中国临床肿瘤学会(CSCO)头颈部肿瘤诊疗指南》2022版.
[4].Sharabi AB,et al.Lancet Oncol.2015;16(13):e498-509.
[5].Protocol specified final results of the KEYNOTE048 Trial of Pembrolizumab as first line therapy for tecurrent/metastatic Head and Neck Squamous Cell Carcinoma,ASCO 2019.Abs 6000.
[6].Clump DA,et al.ASCO 2022.Abs 6007.
[7].Lee,et al.Lancet Oncol.2021.
[8].YG Tao.et al.2021 ESMO.LBA35.
本文仅供医学药学专业人士阅读